November 9, 2021
Life Sciences
  • Pfizer is expected to seek FDA authorization as soon as this week for a booster shot for people 18 and older. According to three officials, the agency is likely to clear the shots. The move could increase booster rates at a time when COVID-19 cases and deaths appear to be plateauing at a high level. (Articles here, here, and here)